🕵️ PLUS Therapeutics, Inc. ($PSTV)
SEC insider & ownership activity, last 12 months · CIK 1095981 · every row links its SEC filing
Over the last 12 months insiders bought $64K with no open-market selling against it. Robert P. Lenk bought $54K in discretionary trades (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $64K (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Robert P. Lenk | 1 | $54K | 0 | – | Aug 22, 2025 |
| SIMS Andrew JOHN HUGH Macintyre | 1 | $10K | 0 | – | Nov 4, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 7.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Other events (8.01) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 1, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 9, 2026 | filing ↗ |
| Other events (8.01) | Jan 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 22, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |